Veracyte Highlights Publication Of Data Showing `Real-World Performance of the Afirma GSC in Thyroid Cancer Diagnosis`
(World News Science)

Cboe - Market News Story Veracyte Highlights Publication Of Data Showing `Real-World Performance of the Afirma GSC in Thyroid Cancer Diagnosis` Benzinga Newsdesk 6/10/2019 3:16:09 PM Veracyte, Inc. (NASDAQ:VCYT) announced today that findings from a new real-world study show that the company`s Afirma® Genomic Sequencing Classifier (GSC) helps to identify significantly more benign thyroid nodules and further reduce unnecessary surgeries in thyroid cancer diagnosis, as compared to the original Afirma test....